Navigation Links
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Date:8/23/2007

ncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the potential failure of XL880 and Exelixis' other compounds to demonstrate safety and efficacy in clinical testing, risks related to Exelixis' dependence on and relationship with GSK and risks related to Exelixis' need for additional financing. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis' Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 and Exelixis' other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Exelixis' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
2. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
3. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
7. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
8. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
9. Salix Pharmaceuticals Previews Digestive Disease Week 2007
10. Reatas Synthetic Triterpenoids Profiled in Nature Reviews Cancer
11. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Decision Resources Group finds that ... $14 billion in 2013 to over $18.2 billion in 2023 in ... , Germany , Italy , ... and Japan . TNF-alpha inhibitors will remain ... the RA market, but growth will be constrained and patient shares ...
(Date:9/16/2014)... , Sept. 16, 2014   Evana Automation ... custom, automated assembly and test systems, recently received a ... leading medical device manufacturer. The Evana solution will help ... and ergonomics, as well as reduce labor. ... fed to Evana,s robotic assembly cell. The robot will ...
(Date:9/16/2014)... , Sept. 16, 2014 The ... Directors Institute has simultaneously released the NAMCP Medical ... Medical Diagnostics Dossier Template © , which provide ... formats for either medical devices or diagnostics that ... of each of these technology types (instead of ...
Breaking Medicine Technology:The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2
... 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... present at the Sixth Annual JMP Securities Healthcare Conference on ... a.m. Pacific Time) at The St. Regis New York Hotel ... Executive Officer, is scheduled to provide a corporate overview. ...
... MINNEAPOLIS, Sept. 21, 2011 Uroplasty, Inc. (NASDAQ: ... markets innovative proprietary products to treat voiding dysfunctions, announced today ... President and CFO, will present the Company,s business strategy and ... at 2:30 PM ET on Tuesday, September 27, 2011 at ...
Cached Medicine Technology:Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 3Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference 2
(Date:9/16/2014)... HORAN, a leading advisor in employee benefits ... as Vice President – Retirement Services. , Paul works ... planning. In addition, he monitors investments, fees and providers ... has been a retirement services industry professional for over ... a Senior Investigator at the Department of Labor facilitates ...
(Date:9/16/2014)... 16, 2014 Since the adoption of ... risen considerably in line with increased investment in R&D ... labels include novel paediatric information and more than 130 ... European countries, there has been 221 changes relating to ... submission of old or new trials in children and ...
(Date:9/16/2014)... 2014 This month’s issue features a ... newly elected chairman, Robert Vail of Vail Automotive in ... further the causes of the state’s franchised new car ... the retail automotive industry’s top names including Jenn Reid ... important to take a “360 view” of the customer ...
(Date:9/16/2014)... 2014 LiveOps, the global leader ... announced today that the company has received a ... the creation of a social learning ecosystem and ... Group honors companies that have successfully developed and ... that have helped companies achieve measurable results. This ...
(Date:9/16/2014)... Hudson County, NJ (PRWEB) September 16, 2014 ... that a leading Bariatric Surgeon, Leigh Montes, MD, ... of Bariatric Surgery at Christ Hospital. Our system ... Bariatric Center, a medical and surgical weight loss ... through the most advanced bariatric surgery procedures, including ...
Breaking Medicine News(10 mins):Health News:Paul Carl Joins HORAN's Retirement Plan Consulting Organization 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3Health News:September Issue of Car Biz Today Magazine Available Online 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3
... When the Spanish capital Madrid decided to replace the thin ... the kind of move that millions of women// around the ... measures to ban very skinny fashion models and to promote ... international interest, a spokesman for the regional government says. ...
... recent research shows that the translaminar approach to cervical ... percent of those treated. ,In addition ... found to be safer than an alternative method or ... alternative approach, steroids are injected in close proximity to ...
... kick the butt. There will be no escape into outdoor areas ... bill// of British Columbia hits the public. ,The new ... in all indoor public spaces as well as in public doorways, ... accessible by the public. , Says Health Minister George ...
... it comes to health care for our kids, we live ... tougher. That is the underlying message// from three University of ... complete overhaul of the U.S child health care system. ... issue of the journal Health Affairs, Dr. Neal Halfon, director ...
... found two of three newer antipsychotic drugs are more ... older medication, according to a research. ,The ... longstanding Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). Dr. ... School of Medicine, is the lead author. ...
... specialists have underlined the urgency to uplift end of life care. ... the flaws// in the healthcare system that do not adequately ... ,Our health care systems do not reliably meet the needs of ... write Sydney Dy and Joanne Lynn, two palliative care doctors based ...
Cached Medicine News:Health News:Spain Launches Movement Against Skinny Fashion Models 2Health News:Spain Launches Movement Against Skinny Fashion Models 3Health News:Neck Pain Treatment Safer Without Significant Risk of Paralysis 2Health News:U.S. Child Health System Needs Total Overhaul 2Health News:Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia 2Health News:Care During Last Phase of Life Needs to Be Uplifted 2
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
Inquire...
EL-RF/3 is for measurement of IgM, IgG, IgA RF with high specificity for rheumatoid arthritis....
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: